末梢血铜蓝蛋白的检测及临床应用

采用火箭电泳法对４６２例儿童和８０例成人及２６４例１０种不同疾病的患儿作末梢血铜蓝蛋白（ＣＰ）检测。结果显示,健康组：新生儿（脐带血）为最低,其均值为６２．１１ｍｇ／Ｌ,以后随月龄增大,ＣＰ含量逐渐增加,２岁时达到最高值,其均值为２５０．２２ｍｇ／Ｌ,以后随年龄增大而ＣＰ含量又逐渐降低,至１０￣１４岁时与成人男子水平接近。病人组：肝豆状核变性,Ⅱ度营养不良,肾病综合症、硬肿症等４种疾病与相应健康儿     

极大螺旋藻(Spirulina maxima)藻蓝蛋白基因的克隆及其同源性分析

藻蓝蛋白是红藻和蓝绿藻中一种重要的捕光色素蛋白．克隆了编码极大螺旋藻藻蓝蛋白α和β两个亚基的基因，序列分析表明该基因全长为1119bp．β亚基基因位于α亚基基因上游，两个亚基基因序列长度分别为519bp和489bp，中间被111bp的基因片段间隔．除编码α和β两个亚基的开放阅读密码框外，还存在两个潜在的开放阅读密码框，但这两个密码框的意义还不清楚．比较了该藻蓝蛋白氨基酸序列和来自于其他藻类的藻蓝蛋白氨基酸序列的同源性以及藻蓝蛋白α和β两个亚基之间氨基酸序列的同源性，总的来说其同源性在45．9％．99％之间，α和β两个亚基氨基酸序列同源性为27．1％．藻蓝蛋白包含许多疏水性氨基酸，这些疏水性氨基酸在藻胆蛋白的聚集过程中起着极为重要的作用．分析表明编码藻蓝蛋白α和β两个亚基基因的密码子显示出非对称性．     

极大螺旋藻藻蓝蛋白基因在巴斯德毕赤酵母X-33中表达的研究

通过PCR技术克隆了极大螺旋藻藻蓝蛋白基因，构建了克隆载体和表达载体，并将该基因导入巴斯德毕赤酵母X-33基因组，筛选了能够有效表达藻蓝蛋白基因的毕赤酵母工程菌株PC8，从而为发酵法生产藻蓝蛋白奠定了基础。     

口腔颌面部恶性肿瘤患者血清免疫抑制酸性蛋白的研究

为探讨免疫抑制酸性蛋白 (IAP)检测在口腔颌面部恶性肿瘤中的临床应用价值 .采用单向免疫扩散法检测了 6 8例口腔颌面部恶性肿瘤患者及 30例正常对照的血清 IAP.结果表明 :正常人血清 IAP含量为 (346± 10 7) μg/ m L,口腔颌面部恶性肿瘤患者血清 IAP为 (6 73± 149) μg/ m L,两者相比有显著性差异 (P<0 .0 1) ;肿瘤患者的 IAP阳性率高达 85.3% (58/ 6 8) , - 期患者血清IAP水平明显高于 - 期患者 (P<0 .0 1) ,随着临床分期的增加 ,IAP水平也随之增高 ;口腔颌面部鳞癌与唾液腺癌之间 IAP水平无显著性差异 (P>0 .0 5) ;治疗后血清 IAP水平明显下降 (P<0 .0 1) ,复发者血清 IAP复又回升 ,而未复发者 IAP水平处于正常水平 .说明检测口腔颌面部恶性肿瘤患者血清 IAP有助于监视病情的发展、观察疗效及判断预后 ,动态研究可监测肿瘤的复发与转移 .     

工业废水中铜、锌、铬含量的分析与研究

主要介绍了用原子吸收分光光度法分析工业废水中铜、锌、铬元素含量的样品处理方法及过程.该方法快速、准确、灵敏度高,是废水中金属元素含量分析的首选方法.     

工业废水中铜、锌、铬含量的分析与研究

主要介绍了用原子吸收分光光度法分析工业废水中铜、锌、铬元素含量的样品处理方法及过程。该方法快速、准确、灵敏度高,是废水中金属元素含量分析的首选方法。     

动脉粥样硬化性脑梗塞和脑出血患者血浆可溶性血栓调节蛋白水平的研究

目的 探讨血浆可溶性血栓调节蛋白（Soluble thrombmodulin,sTM）与脑梗塞和脑出血患者小血管损伤、动脉粥样硬化的关系。方法 应用酶联免疫吸附方法（Enzyme-Linked Immunosorbent Assays,ELISA），检测60例脑梗塞患者、56例脑出血患者和64例健康对照的sTM水平，并分析sTM与血脂、血压的关系。结果 脑梗塞和脑出血的甘油三脂、舒张期血压明显高于对照组；脑梗塞和脑出血的高密度脂蛋白显著低于对照组；脑出血组的收缩期血压明显高于其他两组；脑梗塞的 胆固醇水平显著高于其他两组；脑出血的sTM显著高于脑梗塞和对照组，而脑梗塞的sTM显著高于对照组。sTM与总胆固醇、甘油三脂、收缩和舒张期血压水平显著正相关；sTM与高密度脂蛋白水平成显著负相关。结论 脑梗塞和脑出血存在由高血压和动脉粥样硬化导致的小血管损伤。sTM是脑卒中的独立危险因子。     

Carbohydrate Deficient Transferrin and Interleukin-6 as Predictors of Fibrosis in Alcohol Cirrhosis

The severity of alcoholic cirrhosis depends on the presence of liver inflammation and fibrogenesis. Previous studies have hypothesized that carbohydrate deficient transferrin can be used as marker of liver impairment in alcoholic liver disease patients. The present study was designed to assess whether carbohydrate deficient transferrin is associated with procollagen III peptide and predict fibrosis in alcohol cirrhosis patients. We enrolled 48 patients with alcoholic cirrhosis and 38 healthy controls. Serum carbohydrate deficient transferrin, procollagen III peptide and interleukin-6 levels were estimated in both groups. Serum carbohydrate deficient transferrin, procollagen III peptide and interleukin-6 were significantly increased in alcoholic cirrhosis patients compared to controls. Stepwise regression analysis showed that carbohydrate deficient transferrin (adjusted R² = 0.313, β = 0.362, p = 0.003) and interleukin-6 (adjusted R² = 0.194, β = 0.459, p = 0.001) were positively associated with procollagen III peptide when age, duration and amount of alcohol consumption were considered as covariates. We conclude that elevated carbohydrate deficient transferrin and interleukin-6 act as predictors of fibrosis in alcoholic cirrhosis.     

Biochemical Evaluation of Patients of Alcoholic Liver Disease and Non-alcoholic Liver Disease

Alcoholic liver disease (ALD) is due to excessive alcohol intake for long duration. Distinguishing ALD from non-ALD (non-alcoholic steatohepatitis, hepatitis of viral origin) is difficult as patient may deny alcohol abuse. Clinical examination, histology and serology may not differentiate these conditions. Accurate diagnosis is important as management of ALD differs from non-ALD patients. The aim of our study was (1) To evaluate the patients of ALD and non-ALD by biochemical parameters compared to controls, (2) To assess whether these parameters can differentiate ALD from non-ALD. Study was carried out on 50 patients of ALD in group I and 35 patients of NASH (non-alcoholic steatohepatitis) and acute viral hepatitis each in group II. Age matched healthy controls n = 50. Selection criteria—history of alcohol intake (amount and duration), clinical examination, sonography of abdomen, serum alanine transaminase (ALT) and bilirubin levels. Blood samples were analyzed for bilirubin, aspartate transaminase (AST), ALT, alkaline phosphatase (ALP), gamma glutamyl transferase (GGT) by kinetic method. Statistical analysis was done by Student unpaired ‘t’ test. Patients of ALD have raised AST/ALT ratio (De Ritis ratio) (>2), ALP and GGT compared to controls (P < 0.01).There is significant difference in AST/ALT ratio, serum GGT and ALP in ALD group compared to that in NASH and acute viral hepatitis (P < 0.05). This study suggests that De Ritis ratio >2 in ALD patients may be due to alcohol induced hepatic mitochondrial injury and pyridoxine deficiency. High GGT and ALP values may indicate enzyme induction by alcohol and mild cholestasis. Thus ALD patients have severe hepatic damage. De Ritis ratio <1 and normal to mild elevation in GGT level in NASH and acute viral hepatitis suggest mild hepatic injury of non-alcoholic origin. Our study concludes that ALD patients can be differentiated from NASH and acute viral hepatitis with certainty by measuring serum AST/ALT ratio, GGT and ALP. These biochemical parameters may help clinicians to support the diagnosis of ALD and non-ALD.     

柴胡疏肝汤加减治疗胃神经官能症

胃神经官能症是一种全身性疾病，乃是由于高级神经活动障碍而导致植物神经系统机能失调，临床主要表现为胃的分泌及运动机能紊乱，而出现呕吐或频繁暖气，患者多为中年妇性，运用柴胡疏肝汤加减治疗胃神经官能症56例均为1997年至1999年杭州市第一人民医院中医科门诊病例，治疗结果提法，只要谨守病机，在中医辨证论治的基础上灵活运用，即可取得满意的疗效。     

Circadian Rhythm of Serum Cortisol in Female Patients with Fibromyalgia Syndrome

Fibromyalgia syndrome (FMS) patients have disturbed sleep patterns which may lead to altered circadian rhythm in serum cortisol secretion. The aim of this study was to assess circadian changes, if any, in serum cortisol levels in female patients with FMS. Cortisol levels were estimated every 6 h during 24 h period; in 40 female patients satisfying ACR criteria for FMS (Age 36.4 ± 9.9), and 40 healthy females without FMS (Age 33.8 ± 11.1). A significant difference in the night time serum cortisol level was observed among the patients and control groups (patients, 12.9 ± 9.7 controls 5.8 ± 3.0; p < 0.01). However, no significant difference was found in serum cortisol levels in patients and control groups in the morning (patients, 28.4 ± 13.2 controls, 27.6 ± 14.5; p > 0.05), afternoon (patients, 14.4 ± 5.6 controls, 14.0 ± 6.6; p > 0.05) and evening hours (patients, 10.9 ± 5.8 controls, 8.9 ± 3.6; p > 0.05). It could be concluded that there is an abnormality in circadian secretion of cortisol in female FMS patients.     

肾功能不全患者淋巴细胞内,外电解质的变化

为了了解肾功能不全患者细胞内，外电解质的情况，对１０名健康人，１０名肾功能正常的肾脏病人，１５名肾功能不全的患者进行了淋巴细胞风钾、钠、钙、镁含量以及血清相应电解质浓度的测定，结果表明，肾功能不全患者淋巴细胞内钾含量显著增高，血清钙浓度显著下降。     

Evaluation of Serum Fetuin-A and Osteoprotegerin Levels in Patients with Psoriasis

Psoriasis patients are determined to have a high ratio of coronary artery calcification. Fetuin-A and osteoprotegerin are systemic calcification inhibitors and related to vascular calcification and cardiovascular mortality. In this study we investigated the relationship between fetuin-A and osteoprotegerin levels in psoriasis patients. The study included 40 healthy volunteers and 40 psoriasis patients. Venous blood were collected from healthy volunteers and psoriasis patients in order to search the fetuin-A and osteoprotegerin levels. Disease severity were grouped as mild, moderate and severe according to psoriasis area and severity index (PASI). The relationship between fetuin-A and osteoprotegerin levels and clinical features as sex, PASI and presence of psoriatic arthritis were analyzed. Fetuin-A levels in psoriasis patients were statistically lower than the control group (p < 0.001). In serum osteoprotegerin levels, no statistically significant difference was found in two groups (p > 0.05). Serum fetuin-A and osteoprotegerin level differences were not statistically significant between patients with psoriatic arthritis history and those without. When we grouped patients in respect of their sexes fetuin-A and osteoprotegerin levels of males and females were not significantly different (p > 0.05). No correlation was detected between the ages and PASI scores and the fetuin-A and osteoprotegerin levels of patients. As a result fetuin-A levels in psoriasis patients are found to be low but not related to disease severity. In the light of our results we concluded that fetuin-A may have a role in psoriasis pathogenesis and may contribute to the calcification process developed in psoriasis.     

Serum Lp(a) in diabetics with and without evidence of clinical nephropathy—A preliminary study

Type 2 diabetes is associated with a marked increase in the risk of coronary artery disease. Dyslipidaemia is believed to be a major cause of this increased risk. Recently, elevated levels of lipoprotein (a), Lp(a), have been reported to be associated with an increased risk. However there is very little data regarding Lp(a) concentrations and type 2 diabetes from India. The objective of the study was to assess serum Lp(a) levels in type 2 diabetics with and with out evidence of clinical nephropathy. We estimated serum Lp(a) levels in 30 control subjects, 30 diabetics without evidence of clinical nephropathy and 30 diabetics with evidence of clinical nephropathy. Statistical analysis showed that Lp(a) levels were increased in diabetic patients with nephropathy (mean 46.3±17.6 mg/dl). The Lp(a) levels however did not differ significantly between control (mean 20.2±15.9 mg/dl) and diabetics without nephropathy (mean 22.6±13.1mg/dl). Thus diabetes per se seems to have little or no influence on serum Lp(a) levels, however elevated levels were seen in patients with nephropathy.     

108例病毒性肝炎患者血清补体的研究

报告１０８例病毒性肝炎患者血清总补体（ＣＨ＿（５０））和Ｃ＿３值的检测结果：急性肝炎的ＣＨ＿（５０）为６８．４±６．１３单位／ｍｌ，Ｃ＿３为１３０．２±６．６７ｍｇ％，均高于正常组（ＣＨ＿（５０）为４８．５±５．７５单位／ｍｌ，Ｃ＿３为１０２±５ｍｇ％），Ｐ＜０．０１；其他类型的肝炎患者组的补体均低于正常组，Ｐ＜０．０１．补体的含量与Ｔ细胞花环（Ｅｔ花环）呈中度相关，与ＧＰＴ呈高度相关，因此测定ＣＨ＿（５０）和Ｃ＿３可作为衡量患者机体免疫功能和判断病毒性肝炎预后的指标之一。     

血糖链抗原125和153在心力衰竭中的意义

目的探讨心力衰竭患者部分肿瘤标志物血浓度的变化情况及其临床意义。方法分别在25例正常人和65例心力衰竭患者（按NYHA心功能分级分为II至IV级）测定血糖链抗原125（CA125）、糖链抗原153（CA153）和脑型钠尿肽（BNP）浓度。结果心力衰竭患者血CA125浓度（74.92&#177;24.92）nmol/L,明显高于正常对照组（20.77&#177;13.64）nmol/L,P〈0.101;BNP浓度（99.48&#177;286.60）nmol/L亦明显高于正常对照组（64.45&#177;42.32）nmol/L,P〈0.101。且CA125浓度与脑钠肽水平存在正相关性（r=0.3316,P〈0.01）。而心力衰竭患者血清中CA153浓度与正常对照组相似,分别为（18.39&#177;12.23）nmol/L与（17.19&#177;14.93）nmol/L,P〉0.05）;CA153浓度与脑钠肽水平间无明显相关性（r=-0.1932,P〉0.05）。结论心力衰竭患者血清肿瘤标志物CA125含量明显升高,与病情严重程度有一定相关性,其变化程度对评价心功能的程度和转归可能有一定的参考价值,另说明其升高亦可见于非恶性肿瘤性疾病。